You are here

olverembatinib

Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage

Fierce Pharma

Fri, 06/14/24 - 11:40 am

Ascentage Pharma

CEL-SCI, Jazz, CARsgen, Ascentage and Portage Showcase New Data at ASCO

BioSpace

Wed, 06/8/22 - 10:37 am

Jazz Pharmaceuticals